Sigma Planning Corp - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$3,536
-29.3%
32,0000.0%0.00%
Q3 2022$5,000
-37.5%
32,0000.0%0.00%
Q2 2022$8,000
-52.9%
32,0000.0%0.00%
-100.0%
Q1 2022$17,000
-15.0%
32,0000.0%0.00%0.0%
Q4 2021$20,000
-39.4%
32,0000.0%0.00%0.0%
Q3 2021$33,000
-44.1%
32,0000.0%0.00%
-50.0%
Q2 2021$59,000
-6.3%
32,0000.0%0.00%0.0%
Q1 2021$63,000
+57.5%
32,0000.0%0.00%
+100.0%
Q4 2020$40,000
-31.0%
32,0000.0%0.00%
-50.0%
Q3 2020$58,00032,0000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders